mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease-Reference-Cited by-同舟云学术

mdm2 gene amplification is associated with luminal breast cancer progression in humanized PDX mice and a worse outcome of estrogen receptor positive disease

Published:2021-12-28 Issue: Volume: Page:
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Wege Anja Kathrin¹,Rom‐Jurek Eva‐Maria¹,Jank Paul²,Denkert Carsten²,Ugocsai Peter¹,Solbach Christine³,Blohmer Jens‐Uwe⁴,Sinn Bruno⁴,Mackelenbergh Marion⁵,Möbus Volker⁶,Trumpp Andreas⁷,Marangoni Elisabetta⁸,Pfarr Nicole⁹,Irlbeck Christoph¹⁰¹¹,Warfsmann Jens¹⁰¹¹,Polzer Bernhard¹⁰¹¹^ORCID,Weber Florian¹²,Ortmann Olaf¹,Loibl Sibylle¹³,Vladimirova Valentina¹³,Brockhoff Gero¹^ORCID

Affiliation:

1. Department of Gynecology and Obstetrics University Medical Center Regensburg Regensburg Germany

2. Institute of Pathology, Philipps‐University Marburg UKGM University Hospital Marburg Marburg Germany

3. Department of Gynecology and Obstetrics University Hospital Frankfurt Frankfurt Germany

4. Breast Cancer Center Charité Universitätsmedizin Berlin Berlin Germany

5. Department of Gynecology and Obstetrics Schleswig‐Holstein University Hospital Kiel Germany

6. Department of Medicine II, Hematology and Oncology Goethe University of Frankfurt Frankfurt Germany

7. Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ) and DKFZ‐ZMBH Alliance Institute for Stem Cell Technology and Experimental Medicine (HI‐STEM gGmbH), German Cancer Consortium (DKTK) Heidelberg Germany

8. Department of Translational Research, Institute Curie PSL Research University Paris France

9. Institute of Pathology Technical University Munich Munich Germany

10. Division of Personalized Tumor Therapy Fraunhofer Institute for Toxicology and Experimental Medicine Regensburg Germany

11. Department of Experimental Medicine University of Regensburg Regensburg Germany

12. Institute of Pathology University of Regensburg

13. German Breast Group GBG Forschungs GmbH Neu‐Isenburg Germany

Funder

Deutsche Krebshilfe

Publisher

Wiley

Subject

Cancer Research,Oncology